Blincyto (blinatumomab) - Astellas, Amgen
ssCART-19 - Shanghai Unicar
Actemra IV (tocilizumab) - Roche, JW Pharma
https://meetings-api.hematology.org/api/abstract/vmpreview/298639
 
Wenjun Zhang1; Xiyang Liu2; Hongjia Zhu3; Hongfei Gu4; Fangce Wang1; Chenbo Sun1; Wei Zhang2; Liqing Kang3; Yi Ding1; Jiayong Wang1; Huan Zhou2; Xue Lu2; Xingyue Wang2; Wei Wang3; Zhou Yu3; Jingwen Tan5; Jing Ye6; Israth Jahan Tuhin 3; Nan Xu3; Xiaoyan Lou3; Minghao Li3; Shaoguang Li7; Lei Yu3; Peihua Lu8; Aibin Liang1
 
Nov 4, 2025
 
Next